Moderna | MRNA - Market Capitalization


Moderna reported $20.99B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.8B 724M Mar/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amgen USD 189.89B 13.64B Mar/2026
Arrowhead Research USD 8.78B 236M Mar/2026
Biogen USD 31.9B 5B Jun/2026
BioMarin Pharmaceutical USD 10.86B 553M Mar/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 4.58B 2.8B Mar/2026
Divis Laboratories Ltd INR 1.58T 118.27B Mar/2026
Gilead Sciences USD 172.99B 20.71B Mar/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Incyte USD 22.65B 3.92B Jun/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Kangmei Pharma CNY 24.48B 3.45B Mar/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 142.92M 19.65M Feb/2026
Organigram Holdings CAD 252.47M 59.69M Mar/2026
Ovoca Bio EUR 6.12M 4.93M Apr/2026
Qiagen NV USD 8.27B 1.62B Mar/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Sarepta Therapeutics USD 2.28B 30M Mar/2026
Sartorius EUR 15.63B 1.38B Jun/2026
Ultragenyx Pharmaceutical USD 2.06B 159M Mar/2026
United Therapeutics USD 25.19B 4.21B Mar/2026
Vertex Pharmaceuticals USD 113.58B 1.44B Mar/2026
Zealand Pharma A/S 33.35B 448.34M Dec/2025